Healthcare & Life Sciences~72 peopleSan Francisco, CA, USA
Next-generation DNA synthesis using enzymes
Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.
Pressurl: https://news.google.com/rss/articles/CBMiggJBVV95cUxNRGRUTDVtOXVTU2ZlOHJVck1XU0RJUV9aRjEtaFFMRFJBZXVPd0U4eG5mZWgzRm1SNEZBb2xKWEhlZjQzZzd2UE9pVmVyZWI5ZUk0bjJ3MnI4akRpTGIzTWZjYnRlWXBzNzNoSHdzSEMzT25nWDFDekV0cnVwM1AyVmVQcjVtdUlFQ0tJWFd1bzB3eGw2TFMybW1kd2MtZ0VWMDhSMjlDYnB6ZGxreDNZOXNBVGR2Y1J4VlBqNFVwbFpYZG83VkxUWXEyWFVGMXFGREhfUkRLZkFFX1Faa2R3dTJnaXJ3bDM5WXRXMkx1TE5JYUJRZDE1Ynl1S1JHZTUxU0E?oc=5 · headline: Ansa Biotechnologies Breaks Traditional Synthetic DNA Length Barriers and Redefines Future of Life Science Research · publication: Business Wiregoogle_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMitgFBVV95cUxQVXY5eHN3Vkd0LUlMVG5qMzJPc0t3ek9oaVcwUU5sYlpMZXpnS3BUUEpTazB3TFI3ZnU4RXFHTnZ2cVdtYmxrNENVeUtJTElvb1d6amlrcnVyUl9iUm9tMWZtdUtQV24yV1gyWnNJU2N4U2NiSDBEOXE1OWx6LXhXWVhfcVR2bE1qc0hHbVB2YjdBUmR0a1JWNmNlQWN0VkFNZVFsckZnN1dHcUFoS3IzX08wQTFEUQ?oc=5 · headline: Ansa Biotechnologies Sets New Standard in Long, Complex DNA · publication: Business Wiregoogle_news · 9/15/2026
Pressurl: https://news.google.com/rss/articles/CBMi9AFBVV95cUxPS3RsZkZzckl1WktrMzJDVU45RVhRZHpoQTVHWXl6cmQyaWczbDBhNmdoLWZiUExJVm44V0FaN3k1LU1yM0xGaGk1c1p5RS1fTUp3d2VzdVZ5TmpsYmVnaHJETlBlQzNqQlByU3p5NVhQc1l0LUhIZTM4LVdzU1NhMXE0OUpGX1puRDZBSHJ6WEtzalFSNlBtRnQtRmQtWE9aYXpsWUk1bVI3MGdHYngzN05DeEV1QzF0c1plbDVNd1ZSZl9jYUxJXzh6ZHdCZW10Ui1aN1A4NGoyTDdkWjJRakFELXNseFd4QktscDFxOTVpdzhs?oc=5 · headline: Ansa Biotechnologies Redefines What’s Possible in DNA Synthesis with 50 kb Sequence-Perfect Clonal Product · publication: Business Wiregoogle_news · 9/15/2026
Pressurl: https://news.google.com/rss/articles/CBMi7wFBVV95cUxPSEJQd1R3YkdkaGZaMDVXUkFrM1VCR1ZMY0FyNF9FenZQQmp1N2lzRjdnamtCa1FKUGxvdkRXVUhhZ2UwbGIxcjQ4VlFJWXVLWndSYjluRjRCTmFpLTRHQnJNTjVWTVNkdlpIU2JVWGc2WXNPcDR3VFg2Q29aRUZidGgtcUxEZE45dktEUE1tMWdkY1RHcnhGTm5HNjAtNGMzVXdmOWM2TFVVVjloVmJyZnctSVpmdEpMenpTNExTcXhMSnNVNlVaNjBJS2o4YVFCdmtiUjg3R2QxYmdqMmNmeWc4U0FDYVhlYzgydld0OA?oc=5 · headline: Press Release Service: Ansa Biotechnologies Appoints Jason T. Gammack as CEO and Prepares for Launch of Rapid Enzymatic Synthesis Service for Complex DNA Sequences · publication: CRISPR Medicine News
google_news · 9/15/2026
Pressurl: https://news.google.com/rss/articles/CBMijAFBVV95cUxNUjRudHFiTkMya0tBeTA3TnAxLWFmeGszVnNQYXdkcUVNQzdobUpIbldna3lxMG5uNVJMLUZuVnpRNmU3YmkyUWhFcFNxUTg1M3VFUnhjSndVQWtpWlRmZXYtYVNFSHBsdGExTG00elFRRkQ3Ti1MRV9ZVXh0S2F4TWZDQWVJLVdQTHRxSw?oc=5 · headline: Ansa Bio Appoints Dr. Matthew McManus As Chair · publication: citybizgoogle_news · 9/15/2026
Pressurl: https://news.google.com/rss/articles/CBMiwAJBVV95cUxQc25QRG92eVVMb2RfZ2doMVJqTVVOTmpFeVU1UG9tT21hX0Z0N2s2SmtvNHQtLVZxLW5lM2FZd1NFX01HWGhzdUh2LUZXbE0teEJUTVY4MTRzY055TFVJMEN4ajZzMng0Z3ZtbmJnREU3ZDZneF9BWVJFa2RGVGcyNVNPQkFxWTQwNkhvQ2t2QS1IUlBsaXl5T010MFVjV3d6WmphbHNjNzlEbUhCTkg0RS1XNzd3enBBYnNJbXdkcDA4VnFmNi1XNmQ3NHVKM2dEYTR1cU9wSUZqRGhCUTRIeUVQeTVNVEdCY2V6Ti1CdE9rRU5MajVLOFZHMzRJbVZicEtYVDVrQ2xCRzljMTFMVURPY1plRFVOcW01RVZLYURIc2w5TVVVQ3B3c2ExLW11THpwRmlpMmdFSGJ1eDJTTw?oc=5 · headline: Ansa Biotechnologies Secures $54.4 Million in Series B Financing to Redefine How Scientists Access Synthetic DNA with Industry’s First Guaranteed On-Time Service · publication: Business Wiregoogle_news · 9/15/2026
Pressurl: https://news.google.com/rss/articles/CBMinAJBVV95cUxPTTRXYzVpUGJfN2pGczVjNWNaNDBicnlFQ1h6cy0zQWhEd0lMeGVkRUVNN2ZaLXpJaDhhNlotNGVmem1MTnVSUWVwbVdrYUoyTVpZc0NQYTBrdUFpMjRMbG8xTmtISkU3WHhuZ1lheTRyeVppSld0WWlfU2k0MXh1aDdvS3ZuZFVMQURHSExLblhrem1wX3NCbUdpZHA0ZHhCbW1YNkpxbWZhVlhUNnRheEJXYUs1cTQ5NUJ5TG9OdHRrVEpxRWVLM0NOMGd4Y2VkcDFQaXUzOUpSbUFYUnJSQmhWM0lQTzg5RFIyMXRpTnlHMG1CZXYwUElhQURpZjlpUDc2b1VlY1pkOFBIZ0wxUE9hZDdLbkdNMTgzYg?oc=5 · headline: Ansa Biotechnologies Secures $54.4 Million in Series B Financing to Redefine How Scientists Access Synthetic DNA with Industry’s First Guaranteed On-Time Service · publication: SynBioBetagoogle_news · 9/15/2026
Pressurl: https://news.google.com/rss/articles/CBMi8gFBVV95cUxOYzcxUjgza2l5TXdSVWRvRFlzOU9aNWpscGxlaHo5US1GN0ZreDhPV3ZZUXpxcUdvZlpfTzBMRFlOeDV4c0RNemNDSkFBWHZzZ1hPSDBIbmE4MF9rYWtpNjk1djdvUWZXRWJUbE9YTUNiRHBENjIyWVZrOGlfZDZtVUFmUkpSQ3BEY2hIeS1oMGNmb0d3akJwaUoxbmdUNllyLWFjVzNVN2xZa0hvSzdxMG9SbVZicjBFTnlXV3NXMHBOcmNQdHE2N0l6SVJYZkwwTXVNOWJUN1dfV2V2WGwzTkdUYVpIeVVHeHdCZkw1RThJdw?oc=5 · headline: Ansa Biotechnologies Announces Successful de novo Synthesis of World’s Longest Oligonucleotide at 1005 Bases · publication: CRISPR Medicine Newsgoogle_news · 9/15/2026